The Burlington-based company, which currently employs nearly 71,000 people across 100 countries, will provide a live audio webcast of the event through its investor relations portal. The presentation will remain accessible for replay for 180 days following the conference date.

Labcorp maintains a significant footprint in the pharmaceutical sector, having supported more than 85% of all FDA-approved drugs and therapeutic products in 2025. With a volume exceeding 750 million tests performed annually, the company remains a primary service provider for hospitals, researchers, and individual patients seeking diagnostic clarity.